Lindborg Stacy — SEC Form 4 filings
SEC reporting owner CIK 1813667. 23 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2024-03-13 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 25,000 shares, $24,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: purchase of 25,000 shares @ $0.98 ($24,500) in Imunon, Inc., filed 2024-08-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Imunon, Inc. (IMNN) | President and CEO, Director | 20 | 1 leg · 25,000 sh · $24,500 | — | 20 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Director | 3 | — | — | 3 |
Form 4 filings — Lindborg Stacy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 5,504 @ $1.47 | EDGAR |
| 2026-09-01 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 6,822 @ $1.60 | EDGAR |
| 2026-08-17 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 6,615 @ $1.65 | EDGAR |
| 2026-08-04 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 5,010 @ $1.59 | EDGAR |
| 2026-07-21 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,907 @ $1.83 | EDGAR |
| 2026-07-07 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 2,534 @ $1.91 | EDGAR |
| 2026-06-29 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 67,150 @ $1.72 | EDGAR |
| 2026-06-23 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 1,803 @ $1.82 | EDGAR |
| 2026-06-09 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 1,593 @ $2.06 | EDGAR |
| 2026-05-27 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 1,491 @ $2.20 | EDGAR |
| 2026-05-20 | 4 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/award (A): 150,000 (derivative) @ $0.70 | EDGAR |
| 2026-01-06 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 56,187 (derivative) @ $0 | EDGAR |
| 2025-09-09 | 4 | Imunon, Inc. (IMNN) | Option exercise (M): 1,667 @ $0 · Option exercise (M): 1,667 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2024-10-31 | 4/A | Imunon, Inc. (IMNN) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 63,602 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | Imunon, Inc. (IMNN) | Purchase (P): 25,000 @ $0.98 | EDGAR |
| 2024-06-14 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Imunon, Inc. (IMNN) | Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | Grant/award (A): 241,935 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1813667 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →